Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

36321-43-4Naphazoline EP Impurity A

● Auf Lager

Katalog-Nr.::	VL1510001
CAS-Nr.::	36321-43-4
Summenformel::	C₁₄H₁₆N₂O
Molare Masse::	228.29

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 36321-43-4

Parent drug

Naphazoline

IUPAC-Name

N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide

Pharmacopeial Synonyms

Naphthylacetylethylenediamine

Other Synonyms

1-Naphthaleneacetamide, N-(2-aminoethyl)-; N-(2-Aminoethyl)-1-naphthaleneacetamide

SMILES

C1=CC=C2C(=C1)C=CC=C2CC(=O)NCCN

InChl

InChI=1S/C14H16N2O/c15-8-9-16-14(17)10-12-6-3-5-11-4-1-2-7-13(11)12/h1-7H,8-10,15H2,(H,16,17)

Beschreibung

Naphazoline EP Impurity A, also referred to in pharmacopoeias as Naphthylacetylethylenediamine, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Naphazoline. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications.

References

“Development and Validation of a Capillary Electrophoretic Method for the Determination of Degradation Product in Naphazoline HCl Bulk Drug Substance.” Journal of Liquid Chromatography & Related Technologies, 2021, www.tandfonline.com/doi/abs/10.1080/10826079808003408.?QUAN, LIN, and HUA HE. “Treatment with Olopatadine and Naphazoline Hydrochloride Reduces Allergic Conjunctivitis in Mice through Alterations in Inflammation, NGF and VEGF.” Molecular Medicine Reports, vol. 13, no. 4, Feb. 2016, pp.